GSK to shut down tablet-packaging facility in Melbourne
The company has planned to shut down the facility as part of a business transformation. The jobs are expected to be axed around the end of 2014 or
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.
The company will continue evaluating the compound in other hematologic malignancies such as adult acute lymphoblastic leukemia (ALL). Pfizer’s oncology business unit clinical development and medical affairs senior